Market Dynamics

Gradual increase in number of patients suffering from inflammatory bowel disease and increasing R&D activities by major players in collaboration with government organization for development of advanced solutions are major factors expected to drive the growth of global radiation proctitis treatment market. According to National Center for Chronic Disease Prevention and Health Promotion in 2015, an estimated 1.3% of US adults (3 million) reported being diagnosed with IBD. As many as 70,000 new cases of IBD are diagnosed in the United States each year. Government is investing high for the development of present healthcare infrastructure in order to facilitate the R&D activities. Consumer spending on self care is increasing along with approach towards preventive care is resulting in demand for enhanced care solution. Rise in geriatric population in developed and developing countries along with demand for minimally invasive surgical procedures such as Hyperbaric Oxygen (Hbo) and Antioxidants is gaining importance. Research organizations are focused on development of various therapies such as thermal therapy and hyperbaric oxygen therapy in order to lower the risk of treatment.

Increasing penetration of AI in healthcare, high investment by major players for product development activities and introduction of smart products are factors expected to augment the growth of radiation proctitis treatment market. Player’s inclination toward enhancing the product capabilities and deliver product that is highly efficient for treatment with minimal human interaction. Various business opportunities by the government is resulting in emergence of small and mid-size enterprises with innovative solution is expected to positively impact the growth of radiation proctitis treatment market. In 2018, Amandeep Hospital launched a product hyperbaric Oxygen Therapy (HBOT) with the focus to deliver advanced care.  The product helps patients in the quick recovery of wounds especially diabetic foot ulcers and non-healing wounds. This is expected to help the organization to deliver better care to high patient pool. According to American Cancer Society, Inc. about 13,800 new cases of invasive cervical cancer will be diagnosed and about 4,290 women will die from cervical cancer in 2020. Changing lifestyle pattern, prevalence of cervical cancer on rise and with availability of advanced radiation therapy are factors expected to impact the growth of target market. Factors such as lack of awareness among consumers and limited access to advanced medical equipments are expected to hamper the growth of global radiation proctitis treatment market. Lack of developed infrastructure in the developing countries is limiting the hospitals form delivering the advanced treatment. In addition, side-effects of the drugs such as transient nausea and occasional vomiting are limiting the adoption further challenging the growth of radiation proctitis treatment market.

However, factors such as increasing government spending on development of smart healthcare system and deployment of advanced medical devices in order to cater the enhanced care are factors expected to create new opportunities for players operating in the radiation proctitis treatment market. In addition, increasing awareness activities by players and rise in partnership activities in order to enhance the business presence are factors expected to support the revenue transaction of target market.

Segment Analysis by Region

The market in North America is expected to account for major revenue share in the global radiation proctitis treatment market due to high patient pool suffering from chronic diseases. In addition, favorable reimbursement policies and availability of infrastructure for easy adoption of advanced medical devices are factors expected to boost the growth of radiation proctitis treatment market. 

The market in Asia Pacific is expected to witness faster growth in the radiation proctitis treatment market due to increasing awareness among patients related to advanced treatment. In addition, increasing government spending on development of hospital infrastructure and introduction of new products from players operating in the country are factors expected to support the growth of regional market.

Competitive Landscape      

The Global Radiation Proctitis Treatment Market is high highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.

Report coverage

Radiation Proctitis Treatment Market Segment Analysis, 2019

The global radiation proctitis treatment market is segmented into indication, therapy, type, route of administration, and distribution channel. The indication segment is bifurcated into acute radiation proctitis and chronic radiation proctitis. The Distribution channel segment is divided into Hospital Pharmacies, Drug Stores, Retail Pharmacies, and Online Pharmacies. Among the distribution channel the hospital segment is expected to account for major revenue share in the target market due to high government spending on hospital development.

The players profiled in the report Dr Reddy Laboratories, Chugai Pharmaceutical Co Ltd., Nanjing Pharmaceutical Factory Co., Ltd., GlaxoSmithKline, Allergan, Northeast Pharmaceutical, Reckitt & Benckiser, Huanan Pharma, and Sun Pharmaceutical Industries.

Market Segmentation

Market By Indication

Acute Radiation Proctitis

Chronic Radiation Proctitis

Market By Therapy

Oral Therapy

Rectal Instillation Therapy

Thermal Therapy

Hyperbaric Oxygen Therapy

Market By Type

Non-Invasive

• Non-Steroidal Anti-Inflammatory Drugs,
• Sucralfate
• Short-Chain Fatty Acids (Scfa)
• Hyperbaric Oxygen (Hbo)
• Antioxidants

Invasive

Market By Route of Administration

Oral

Intravenous

Market By Distribution Channel

Hospital Pharmacies

Drug Stores

Retail Pharmacies

Online Pharmacies

Market By Region

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC
• South Africa
• Rest of Middle East & Africa